TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioStock AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,713
|
1,784
|
1,779 |
Financial expenses |
1
|
2
|
0 |
Earnings before taxes |
155
|
247
|
592 |
EBITDA |
168
|
260
|
613 |
Total assets |
525
|
875
|
964 |
Current assets |
491
|
829
|
930 |
Current liabilities |
220
|
475
|
437 |
Equity capital |
284
|
378
|
494 |
- share capital |
5
![]() |
5
|
6 |
Employees (average) |
0
|
16
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
54.1%
|
43.2%
|
51.2% |
Turnover per employee |
112
|
148 | |
Profit as a percentage of turnover |
9.0%
|
13.8%
|
33.3% |
Return on assets (ROA) |
29.7%
|
28.5%
|
61.4% |
Current ratio |
223.2%
|
174.5%
|
212.8% |
Return on equity (ROE) |
54.6%
|
65.3%
|
119.8% |
Change turnover |
-76
|
149
|
499 |
Change turnover % |
-4%
|
9%
|
39% |
Chg. No. of employees |
-16
|
4
|
1 |
Chg. No. of employees % |
-100%
|
33%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.